Procedure for Specification Setting According to ICH Q6A Guidelines in Stability Testing

1) Purpose

The purpose of this SOP is to define a procedure for applying ICH Q6A guidelines to establish specifications for stability testing in drug development. This ensures that stability data meets the necessary criteria for maintaining product quality throughout its shelf life.

2) Scope

This SOP applies to all personnel involved in setting specifications for stability testing, including quality control, quality assurance, and regulatory affairs teams.

3) Responsibilities

Quality Assurance Team: Responsible for defining specifications that comply with ICH Q6A guidelines.
Stability Study Team: Responsible for conducting stability tests in accordance with the established specifications.
Regulatory Affairs Team: Responsible for ensuring all specifications are documented and submitted according to regulatory requirements.

4) Procedure

4.1 Specification Setting

4.1.1 Develop specifications for stability testing, including critical quality attributes such as potency, purity, dissolution, and degradation products,

as per ICH Q6A guidelines.

4.1.2 Define acceptable limits for each parameter based on the drug’s intended use, regulatory requirements, and product safety profile.

4.2 Conducting Stability Tests

4.2.1 Perform stability tests in compliance with the established specifications, ensuring that all critical parameters are monitored.

4.2.2 Document all data accurately and ensure that results meet the